Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 57 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]
2.Enlace a cita original Cita con resumen
Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS. Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study. BMJ 2019;364:6 de marzo. [Ref.ID 103059]
3.Enlace a cita original Cita con resumen
Malvezzi M, Carioli G, Bertuccio P, Boffetta P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2019 with focus on breast cancer. Ann Oncol 2019;30:19 de marzo. [Ref.ID 103053]
4.Tiene citas relacionadas Cita con resumen
Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thompson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J, for the WHI Investigators. Menopausal Hormone therapy and long-term all-cause and cause-specific mortality. The Women’s Health Initiative randomized trials. JAMA 2017;318:927-38. [Ref.ID 102070]
5.Tiene citas relacionadas Cita con resumen
McNeil M. Menopausal hormone therapy. Understanding long-term risks and benefits. JAMA 2017;318:911-3. [Ref.ID 102069]
6. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
7. Cita con resumen
Anónimo. Implications of religious and cultural beliefs on selection of medicines. Drug Ther Bull 2016;54:45-8. [Ref.ID 100172]
8. Cita con resumen
Smith NL, Blondon M, Wiggins KL, Harrington LB, van Hylckama Vlieg A, Floyd JS, Hwang M, Bis JC, McKnight B, Rice KM, Lumley T, Rosendaal FR, Heckbert SR, Psaty BM. Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens. JAMA Intern Med 2014;174:25-35. [Ref.ID 97020]
9. Cita con resumen
Anónimo. U.S. FDA approves Pfizer drug for menopause symptoms. Journal Watch 2013:4 de octubre. [Ref.ID 96196]
10.Tiene citas relacionadas
Grodstein F. Hormone therapy in younger women and cognitive health. JAMA Intern Med 2013;173:1437-8. [Ref.ID 95978]
11.Tiene citas relacionadas Cita con resumen
Espeland MA, Shumaker SA, Leng I, Manson JE, Brown CM, LeBland ES, Vaughan L, Robinson J, Rapp SR, Goveas JS, Lane D, Wactawski-Wende J, Stefanick ML, Li W, Resnick SM, WHIMSY Study Group. Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med 2013;173:1429-36. [Ref.ID 95976]
12. Cita con resumen
Moyer VA, and on behalf of the U.S. Preventive Services Task Force. Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013;158:47-54. [Ref.ID 94682]
14. Cita con resumen
Jungheim ES, Colditz GA. Short-term use of unopposed estrogen. A balance of inferred risks anb benefits. JAMA 2011;305:1354-5. [Ref.ID 90530]
15.Tiene citas relacionadas
Chlebowski RT, Stefanick ML, Anderson GL. Breast cancer in postmenopausal women after hormone therapy. In reply. JAMA 2011;305:466-7. [Ref.ID 90149]
16.Tiene citas relacionadas
Hermsmeyer RK, Kaski JC, Thompson TL. Breast cancer in postmenopausal women after hormone therapy. JAMA 2011;305:466. [Ref.ID 90148]
17.Tiene citas relacionadas
Baber R. Breast cancer in postmenopausal women after hormone therapy. JAMA 2011;305:466. [Ref.ID 90147]
18.Tiene citas relacionadas
Bach PB. Postmenopausal hormone therapy and breast cancer. An uncertain trade-off. JAMA 2010;304:1719-20. [Ref.ID 89534]
19.Tiene citas relacionadas Cita con resumen
Chlebowski BT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL, for the WHI Investigators. Estrogen plus progesting and breast cancer incidence and mortality in postmenopausal women. JAMA 2010;304:1684-92. [Ref.ID 89533]
20. Cita con resumen
McKinnon RA, Lu CY. Biosimilars are not (bio)generics. Australian Prescriber 2009;32:146-7. [Ref.ID 87186]
Seleccionar todas
 
 1 a 20 de 57 siguiente >>